Average Co-Inventor Count = 7.76
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Elan Pharmaceuticals, Inc. (7 from 202 patents)
2. Imago Pharmaceuticals, Inc. (3 from 5 patents)
3. Alios Biopharma, Inc. (2 from 44 patents)
4. Janssen Biopharma, Inc. (2 from 20 patents)
5. University of Utah Research Foundation (1 from 1,644 patents)
15 patents:
1. 11021444 - Antiviral compounds
2. 11014935 - Compounds for the treatment of paramyxovirus viral infections
3. 10358453 - Antiviral compounds
4. 9884828 - Substituted cinnolines as inhibitors of LRRK2 kinase activity
5. 9796706 - Inhibitors of Jun N-terminal kinase
6. 9724351 - Compounds for the treatment of paramoxyvirus viral infections
7. 9096550 - Bryostatin analogues and methods of making and using thereof
8. 9073891 - Inhibitors of Jun N-terminal kinase
9. 8541418 - Inhibitors of polo-like kinase
10. 8450363 - Inhibitors of Jun N-terminal kinase
11. 8445503 - Inhibitors of polo-like kinase
12. 8283358 - N-sulfonamido polycyclic pyrazolyl compounds
13. 7906556 - Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
14. 7754712 - Bridged N-cyclic sulfonamido inhibitors of gamma secretase
15. 7345056 - Bridged N-cyclic sulfonamido inhibitors of gamma secretase